Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia

Cancer

Volumn 88, Issue 11, 2000, Pages 2520-2528

  Ruol, Alberto ^a,c   Parenti, Anna ^a   Zaninotto, Giovanni ^a   Merigliano, Stefano ^a   Costantini, Mario ^a   Cagol, Matteo ^a   Alfieri, Rita ^a   Bonavina, Luigi ^b   Peracchia, Alberto ^b   Ancona, Ermanno ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Barrett esophagus; Esophageal adenocarcinoma; Gastric cardia adenocarcinoma; Intestinal metaplasia; Oncology; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CARDIA CARCINOMA; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; METAPLASIA; PRIORITY JOURNAL; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; CARCINOMA IN SITU; CARDIA; CHI-SQUARE DISTRIBUTION; ESOPHAGOGASTRIC JUNCTION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 18744434014     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000601)88:11<2520::AID-CNCR13>3.0.CO;2-L     Document Type: Article

References (69)

1. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104:510-3.
2. Kalish RJ, Clancy PE, Orringer MB, Appelman HD. Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's mucosa and in the gastric cardia. Gastroenterology 1984;86:461-7.
3. Wang HH, Antonioli DA, Goldman H. Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. Hum Pathol 1986;17:482-7.
4. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
5. Hesketh PJ, Clapp RW, Doos WG, Spechler SJ. The increasing frequency of adenocarcinoma of the esophagus. Cancer 1989;64:526-30.
6. Powell J, Pera M, Cameron AJ, Transtek VF, Carpenter HA, Zinsmester AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
7. Husemann B. Cardia carcinoma considered as a distinct clinical entity. Br J Surg 1989;76:136-9.
8. Riddell RH. Early detection of neoplasia of the esophagus and gastroesophageal junction. Am J Gastroenterol 1996;91: 853-63.
9. Tytgat GNJ, Hameeteman W. The neoplastic potential of columnar-lined (Barrett's) esophagus. World J Surg 1992;16: 308-12.
10. Tytgat GNJ. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value? Endoscopy 1995;27:19-26.
11. th World Congress of the International Society for Diseases of the Esophagus. Kyoto: ISDE Press, 1992:94.
12. Ruol A, Merigliano S, Baldan N, Santi S, Bonavina L, Ancona E, et al. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophagogastric junction. Comparison between early cancer in Barrett's esophagus (type I) and early cancer of the cardia (type II). Dis Esophagus 1997;10:190-5.
13. Johansson J, Johnsson F, Walther B, Villen R, VonHolstein CS, Zilling T. Adenocarcinoma in the distal esophagus with and without Barrett esophagus. Arch Surg 1996;131:708-13.
14. Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett's esophagus. Br J Surg 1997;84:1470-3.
15. Reid BJ, Weinstein WM, Lewin KJ, Haggitt RC, VanDeventer G, DenBesten L, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988;94:81-90.
16. Hamilton SR, Smith RRC, Cameron JL. Prevalence and characteristics of Barrett's esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988;19:942-8.
17. Appelman HD, Kalish RJ, Clancy PE, Orringer MB. Distinguishing features of adenocarcinoma in Barrett's esophagus and in the gastric cardia. In: Spechler SJ, Goyal RK, editors. Barrett's esophagus: pathophysiology, diagnosis, and management. New York: Elsevier, 1985:167-87.
18. Morales TG. Adenocarcinoma of the gastric cardia. Dig Dis 1997;15:346-56.
19. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 1981;11:127-39.
20. Lauren P. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal type adenocarcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
21. Hermanek P, Sobin LH. Digestive system tumors: stomach. In: Hermanek P, Sobin LH, editors. TNM classification of malignant tumors. Berlin: Springer, 1987:43-6.
22. Hayward J. The lower end of the esophagus. Thorax 1961; 16:36-41.
23. Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996;110:614-21.
24. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinoma arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992;37:137-43.
25. Haggitt RC. Barrett's esophagus dysplasia and adenocarcinoma. Hum Pathol 1994;25:982-3.
26. Weinstein WM, Ippoliti AF. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc 1996;44: 91-5.
27. Gottfried MR, McClave SA, Boyce HW. Incomplete intestinal metaplasia in the diagnosis of columnar lined esophagus (Barrett's esophagus). Am J Clin Pathol 1989;92:741-6.
28. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, "carditis", and Barrett's esophagus, and sequelae of therapy. Am J Surg Pathol 1996;20(Suppl 1):S31-50.
29. Spechler SJ. Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice? Ann Intern Med 1987;106:902-4.
30. Ireland AP, Clark GWB, DeMeester TR. Carcinoma of the cardia: role of short-segment Barrett's esophagus and columnar metaplasia. Dis Esophagus 1996;9:159-64.
31. Puestow CB, Gillesby WJ, Guynn VI. Cancer of the esophagus. Arch Surg 1955;70:662-8.
32. Turnbull ADM, Goodner IT. Primary adenocarcinoma of the esophagus. Cancer 1968;22:915-8.
33. Bosch A, Frias Z, Caldwell WI. Adenocarcinoma of the esophagus. Cancer 1979;43:1557-61.
34. Harrison SC, Goldacre MJ, Seagroatt V. Trends in registered incidence of esophageal and stomach cancer in the Oxford region 1974-88. Eur J Cancer Prev 1992;2:271-4.
35. Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609-14.
36. Haggitt RC, Tryzelaar J, Ellis FH, Colcher H. Adenocarcinoma complicating columnar epithelium-lined esophagus. Am J Clin Pathol 1978;70:1-5.
37. Clark GWB, Smyrk TC, Hoeft SF, Burdiles P, Dreuw B, Crookes PF, et al. Is the length of Barrett's mucosa related to the prevalence of complications and adenocarcinoma in Barrett's esophagus? Gastroenterology 1993;104:A393.
38. Cameron AS, Lomboy CT, Pera M, Carpenter A. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-6.
39. MacDonald WC, MacDonald JB. Adenocarcinoma of the esophagus and or gastric cardia. Cancer 1987;60:1094-8.
40. Lomboy CT, Pera M, Cameron AJ, Carpenter HA, Trasek VF. Adenocarcinoma of the esophagus and esophagogastric junction are both associated with Barrett's epithelium. Gastroenterology 1992;102(Suppl):A373.
41. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26: 487-94.
42. Clark GWB, Ireland AP, Chandrasoma P, DeMeester TR, Peters JH, Bremner C. Inflammation and metaplasia in the transitional epithelium of the gastroesophageal junction: a new marker for gastroesophageal reflux disease. Gastroenterology 1994;106(Part 2):A63.
43. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-esophageal junction. Lancet 1994;344:1533-6.
44. Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol 1997;92: 414-8.
45. Quddus MH, Henley JD, Sulaiman RA, Palumbo TC, Gnepp DR. Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus. Hum Pathol 1997;28:1007-9.
46. Wright TA, Myskow M, Kingsnorth AN. Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer. Dis Esophagus 1997;10:196-200.
47. Henihan RDJ, Stuart RC, Nolan N, Gorey TF, Hennessy TP, O'Morain CA. Barrett's esophagus and the presence of Helicobacter pylori. Am J Gastroenterol 1998;93:542-6.
48. Oberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, Ireland AP, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997;226:522-32.
49. Parsonnett J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325: 1127-31.
50. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, et al. Gastric adenocarcinoma and Helicobacter Pylori infection. J Natl Cancer Inst 1991;83: 1734-9.
51. Hansson LE, Engstrand L, Nyren O, Lindgren A. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995;109:885-8.
52. Spechler SJ, Wang HH, Chen YY, Zeroogian JM, Antonioli DA, Goyal RK. Inflammation of the gastric cardia and H. pylori infection are not risk factors for intestinal metaplasia at the esophagogastric junction [abstract]. Gastroenterology 1997;112:A297.
53. Goldblum JR, Vicari JJ, Falk GW, Rice TW, Peek RM, Easley K, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998;114:633-9.
54. Hirota WK, Lougheney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RKH. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85.
55. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
56. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
57. Knawy BA, Morad NA, Jamal A, Hamdi J, Mirdad S. Non-neoplastic changes in gastric antrum: are they different in distally located intestinal and diffuse-type gastric adenocarcinoma? Eur J Cancer Prev 1997;6:167-70.
58. Al-Knawy B, Morad N, Jamal A, Mirdad S, Abol Fotouh M, Ahmed ME, et al. Helicobacter pylori and intestinal metaplasia with its subtypes in the gastric antrum in Saudi population. Scand J Gastroenterol 1999;34:562-5.
59. Safatle-Ribeiro AV, Ribeiro U, Clarke MR, Sakai P, Ishioka. S, Garrido AB, et al. Relationship between persistence of Helicobacter Pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation following partial gastrectomy. Dig Dis Sci 1999;44:243-52.
60. Sobala GM, O'Connor HJ, Dewar EP, King RFG, Axon ATR, Dixon MF. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol 1993;46:235-40.
61. Offerhaus GJ, van de Stadt J, Huibregtse K, Tersmette AC, Tytgat GN. The mucosa of the gastric remnant harboring malignancy. Histologic findings in the biopsy specimens of 504 asymptomatic patients 15 to 46 years after partial gastrectomy with emphasis on nonmalignant lesions. Cancer 1989;64:698-703.
62. Domellof L, Eriksson S, Janunger KG. Late occurrence of precancerous changes and carcinoma of the gastric stump after Billroth II resection. Acta Chir Scand 1975;141:292-7.
63. Leivonen M, Nordling S, Haglund C. Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types? Anticancer Res 1997;17:3893-6.
64. Gregory P, Bhathal PS, Abbott M, Thomas RJS, Mortsyn G. Clinical and pathologic similarity between adenocarcinoma of Barrett's esophagus and gastric cardia. Dis Esophagus 1989;2:191-5.
65. Peracchia A, Bardini R, Asolati M, Ruol A, Bonavina L, Castoro C, et al. Surgical treatment of carcinoma of the gastric cardia. Hepato-Gastroenterol 1991;38(Suppl 1):72-5.
66. Ellis FH, Gibb SP, Watkins E. Limited esophagogastrectomy for carcinoma of the cardia: indications, technique, and results. Ann Surg 1988;208:354-61.
67. Thomas P, Doddoli C, Lienne P, Morati N, Thirion X, Garbe L, et al. Changing patterns and surgical results in adenocarcinoma of the esophagus. Br J Surg 1997;84:119-25.
68. Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery 1998;123: 127-30.
69. Holscher AH, Bollschweiler E, Siewert JR. Carcinoma of the gastric cardia. Ann Chir Gynecol 1995;84:185-92.